首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels.
【24h】

The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels.

机译:非酒精性脂肪肝患者血浆胆固醇酯的脂肪酸组成和估计的去饱和酶活性,以及​​长期依泽替米贝治疗对这些水平的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The aim of this study was to investigate the relationship between fatty acid composition of plasma cholesteryl esters (CEs) and estimated desaturase activity and the development and progression of nonalcoholic fatty liver disease (NAFLD). The study also assessed the effect of ezetimibe on CE levels. METHODS: Plasma CEs fatty acid composition was analyzed in 3 groups: patients with a NAFLD activity score (NAS) /= 5 (n=32) and normal controls (n=25). The estimated desaturase activities were calculated using ratios of 16:1n-7/16:0 (D9-16D), 18:1n-9/18:0 (D9-18D), 18:3n-6/18:2n-6 (D6D) and 20:4n-6/20:3n-6 (D5D). RESULTS: Compared with controls, the levels of palmitate, palmitoleate, gamma-linoleate, D9-16D and D6D were significantly increased, whereas levels of linoleate and D5D were significantly decreased. Patients with NAS >/= 5 had significantly higher palmitate levels than patients with NAS
机译:背景:本研究的目的是研究血浆胆固醇酯(CEs)的脂肪酸组成与估计的去饱和酶活性以及非酒精性脂肪肝疾病(NAFLD)的发展之间的关系。该研究还评估了依泽替米贝对CE水平的影响。方法:血浆CEs脂肪酸组成分为3组:NAFLD活性评分(NAS) / = 5(n = 32)和正常对照组(n = 25) 。使用16:1n-7 / 16:0(D9-16D),18:1n-9 / 18:0(D9-18D),18:3n-6 / 18:2n-6的比率计算估算的去饱和酶活性(D6D)和20:4n-6 / 20:3n-6(D5D)。结果:与对照组相比,棕榈酸酯,棕榈油酸酯,γ-亚油酸酯,D9-16D和D6D的含量显着升高,而亚油酸酯和D5D的含量则显着降低。 NAS> / = 5的患者的棕榈酸酯水平明显高于NAS

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号